195 related articles for article (PubMed ID: 15461239)
1. If not sulfonylureas, then what?
Leibovitch ER
Geriatrics; 2004 Sep; 59(9):47-8. PubMed ID: 15461239
[No Abstract] [Full Text] [Related]
2. Oral sulfonylureas and CV mortality.
Aronow WS
Geriatrics; 2004 Sep; 59(9):45-6, 49. PubMed ID: 15461238
[No Abstract] [Full Text] [Related]
3. Late complications of diabetes mellitus: risk factors in patients on sulfonylureas for more than 10 years.
Hoshi M; Fujita S
Jpn J Med; 1991; 30(6):616-7. PubMed ID: 1798228
[No Abstract] [Full Text] [Related]
4. Long-acting sulfonylureas -- long-acting hypoglycaemia.
Veitch PC; Clifton-Bligh RJ
Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
[No Abstract] [Full Text] [Related]
5. Sulfonylureas and the risk of myocardial infarction.
Thisted H; Johnsen SP; Rungby J
Metabolism; 2006 May; 55(5 Suppl 1):S16-9. PubMed ID: 16631805
[TBL] [Abstract][Full Text] [Related]
6. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
Standl E; Schnell O
Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
[No Abstract] [Full Text] [Related]
7. Sulfonylureas and mortality in diabetic patients after myocardial infarction.
Brady PA; Al-Suwaidi J; Kopecky SL; Terzic A
Circulation; 1998 Feb; 97(7):709-10. PubMed ID: 9495313
[No Abstract] [Full Text] [Related]
8. Don't throw the baby out with the bath water: mortality with combination metformin and sulfonylurea.
Tayek JA
Diabetes Metab Res Rev; 2007 Feb; 23(2):85-6. PubMed ID: 17262894
[No Abstract] [Full Text] [Related]
9. Glimepiride-induced vasculitis: a case report.
Ben Salem C; Hmouda H; Bouraoui K
Br J Clin Pharmacol; 2007 Jul; 64(1):113-4. PubMed ID: 17324240
[No Abstract] [Full Text] [Related]
10. Glimepiride for NIDDM.
Med Lett Drugs Ther; 1996 May; 38(975):47-8. PubMed ID: 8632731
[No Abstract] [Full Text] [Related]
11. A comment on 'the risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy'.
Chang Y; Choi NK; Hahn S; Park BJ
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1072-3; author reply 1073-4. PubMed ID: 17907252
[No Abstract] [Full Text] [Related]
12. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189
[No Abstract] [Full Text] [Related]
13. Pioglitazone/glimepiride (Duetact) for diabetes.
Med Lett Drugs Ther; 2007 Jan; 49(1253):9-11. PubMed ID: 17261966
[No Abstract] [Full Text] [Related]
14. Pioglitazone + glimepiride: a combination product to avoid.
Prescrire Int; 2007 Aug; 16(90):145. PubMed ID: 17724836
[No Abstract] [Full Text] [Related]
15. Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?
Riddle MC
J Clin Endocrinol Metab; 2003 Feb; 88(2):528-30. PubMed ID: 12574174
[No Abstract] [Full Text] [Related]
16. Emergency management of oral hypoglycemic drug toxicity.
Rowden AK; Fasano CJ
Emerg Med Clin North Am; 2007 May; 25(2):347-56; abstract viii. PubMed ID: 17482024
[TBL] [Abstract][Full Text] [Related]
17. [Hyperplastic skin reactions as the side effects of sulfonylurea preparations (the clinical manifestations and diagnosis)].
Potekaev NS; Kurdina MI
Ter Arkh; 1992; 64(10):24-6. PubMed ID: 1485245
[No Abstract] [Full Text] [Related]
18. [Hardly any hypoglycemias, constant weight--and still cost effective].
MMW Fortschr Med; 2005 Nov; 147(47):72-3. PubMed ID: 16370200
[No Abstract] [Full Text] [Related]
19. Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795
[No Abstract] [Full Text] [Related]
20. Update on oral hypoglycemics (continuing education credit).
White JR
J Pract Nurs; 1994 Mar; 44(1):24-31; quiz 31-3. PubMed ID: 8158562
[No Abstract] [Full Text] [Related]
[Next] [New Search]
